Ventyx Biosciences, Inc. (VTYX) Financials
VTYX Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 277.7 million | 33.8 million |
2023-09-30 | 321.7 million | 38.1 million |
2023-06-30 | 348.8 million | 21.0 million |
2023-03-31 | 389.2 million | 17.6 million |
VTYX Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -51.9 million | 6.1 million |
2023-09-30 | -34.7 million | 8.0 million |
2023-06-30 | -49.5 million | 7.9 million |
2023-03-31 | -31.0 million | 6.6 million |
VTYX Net Income
No data available :(
VTYX Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 252.2 million | - | 12.5 million |
2023-09-30 | 300.8 million | - | 12.3 million |
2023-06-30 | 332.3 million | - | 1.4 million |
2023-03-31 | 376.9 million | - | 1.5 million |
VTYX Shares Outstanding
VTYX Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 211000 | 40.3 million | 8.3 million | -903000 |
2023-09-30 | 48000 | 49.8 million | 8.2 million | - |
2023-06-30 | 195000 | 48.6 million | 8.6 million | - |
2023-03-31 | 60000 | 35.4 million | 7.1 million | - |
VTYX Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | - | 403000 |
2023-09-30 | - | 265000 |
2023-06-30 | - | 139000 |
2023-03-31 | - | 134000 |
VTYX
Price: $4.91
52 week price:
Earnings Per Share: -3.30 USD
P/E Ratio: -0.70
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 2.2 million
Market Capitalization: 345.1 million